MRNA – moderna, inc. (US:NASDAQ)
Stock Stats
News
Moderna, Inc. (NASDAQ: MRNA) had its price target raised by analysts at Canaccord Genuity Group Inc. from $91.00 to $106.00. They now have a "hold" rating on the stock.
Moderna, Inc. (NASDAQ: MRNA) had its price target raised by analysts at Royal Bank of Canada from $125.00 to $135.00. They now have an "outperform" rating on the stock.
Moderna, Inc. (NASDAQ: MRNA) had its price target raised by analysts at Oppenheimer Holdings Inc. from $142.00 to $163.00. They now have an "outperform" rating on the stock.
Thousands Believe Covid Vaccines Harmed Them. Is Anyone Listening? [The New York Times]
Moderna reports $1.2bn net loss in Q1 2024 [Yahoo! Finance]
Form 4 Moderna, Inc. For: May 01 Filed by: AFEYAN NOUBAR
Form 10-Q Moderna, Inc. For: Mar 31
Form 8-K Moderna, Inc. For: May 02
Form 144 Moderna, Inc. Filed by: AFEYAN NOUBAR
Form 4 Moderna, Inc. For: Apr 24 Filed by: AFEYAN NOUBAR
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.